<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005367A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005367</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>14017013</doc-number><date>20130903</date></document-id></application-reference><us-application-series-code>14</us-application-series-code><priority-claims><priority-claim sequence="01" kind="national"><country>JP</country><doc-number>336310/2007</doc-number><date>20071226</date></priority-claim></priority-claims><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>K</subclass><main-group>1</main-group><subgroup>14</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>K</subclass><main-group>1</main-group><subgroup>14</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>5303873</main-classification></classification-national><invention-title id="d0e61">HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION</invention-title><us-related-documents><division><relation><parent-doc><document-id><country>US</country><doc-number>12810938</doc-number><date>20100628</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8568720</doc-number></document-id></parent-grant-document><parent-pct-document><document-id><country>WO</country><doc-number>PCT/JP2008/073798</doc-number><date>20081226</date></document-id></parent-pct-document></parent-doc><child-doc><document-id><country>US</country><doc-number>14017013</doc-number></document-id></child-doc></relation></division></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>Chugai Seiyaku Kabushiki Kaisha</orgname><address><city>Kita-ku</city><country>JP</country></address></addressbook><residence><country>JP</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>MORICHIKA</last-name><first-name>Toshiyuki</first-name><address><city>Kita-ku</city><country>JP</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Kameoka</last-name><first-name>Daisuke</first-name><address><city>Kita-ku</city><country>JP</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Imaeda</last-name><first-name>Yoshimi</first-name><address><city>Kita-ku</city><country>JP</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Maeda</last-name><first-name>Terutoshi</first-name><address><city>Kita-ku</city><country>JP</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>Stauch</last-name><first-name>Oliver Boris</first-name><address><city>Freiburg</city><country>DE</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>Chugai Seiyaku Kabushiki Kaisha</orgname><role>03</role><address><city>Kita-ku</city><country>JP</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The problem to be solved is to provide an antibody-containing formulation which is stable and suited for subcutaneous administration, wherein dimerization and deamidation is prevented during long-term storage.</p><p id="p-0002" num="0000">The present application is directed to a stable antibody-containing liquid formulation characterized by containing arginine and methionine.</p></abstract></us-patent-application>